96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00583232 (ClinicalTrials.gov) | February 2006 | 20/12/2007 | Protein and Energy Metabolism in Pediatric Crohn's Disease | Protein and Energy Metabolism in Pediatric Crohn's Disease | Crohn's Disease;Protein Metabolism;Energy Metabolism | Drug: Stable isotope infusions | Indiana University | GlaxoSmithKline;Crohn's and Colitis Foundation;National Center for Research Resources (NCRR) | Completed | 6 Years | 18 Years | All | 15 | Phase 1 | United States |